20 August 2014Comments ( 2 )
New estimates on the role of common mutations in autism raise questions about how to quantify and parse genetic risk. Three experts say both common and rare variants are worth pursuing.
6 August 2014Comments ( 4 )
Reports of a century-old drug that reverses autism-like symptoms in mice raise key questions about the complexity of translating promising research into real treatments.
2 July 2014Comments ( 7 )
Watch the complete replay of Robert Malenka’s webinar on the molecular underpinnings of social reward.
16 June 2014Comments ( 4 )
Watch the complete replay of Jeremy Veenstra-VanderWeele’s webinar on conceptual pathways for developing effective autism drugs.
11 June 2014Comments ( 15 )
If inherited risk for autism is 50 percent, does that make the remaining half of risk environmental? Scientists clarify a large population study.